Verrica Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.57-$11.41 |
Market Cap | $55M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $9.2M |
Revenue Growth (YoY) | 2,744.5% |
Gross Profit (12 Mos) | -$13.4M |
Diluted EPS | -$1.84 |
News
See moreYahoo Finance • 13 days ago
Verrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston
Yahoo Finance • 2 months ago
Verrica Pharmaceuticals Announces Presentation of Three Posters Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2025 Winter Clinical Dermatology Conference
Yahoo Finance • 5 months ago
Verrica Pharmaceuticals Inc. (VRCA): Worst 52-Week Low Stock to Buy Now
Yahoo Finance • 5 months ago
Is Verrica Pharmaceuticals Inc. (VRCA) The Worst 52-Week Low Stocks to Buy Now According to Short Sellers?
About
CEO | Dr. Jayson M. Rieger M.B.A., Ph.D. |
CFO | Mr. John J. Kirby CPA |
Address | 44 West Gay Street, West Chester, PA, United States, 19380 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 100 |
